---
title: "INTELLIA THERAPEUTICS, INC. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/2e2de2f6-45fc-50ca-983f-2af9bb7011e8
json: https://whiteintel.dev/api/public/dossier/2e2de2f6-45fc-50ca-983f-2af9bb7011e8
identifier: lei:5493002T5BCPE5DZC723
jurisdiction: US-DE
risk: Low
source: WhiteIntel corporate-ownership graph
---

# INTELLIA THERAPEUTICS, INC.

**Type:** Company  
**Jurisdiction:** US-DE  
**Identifier:** `lei:5493002T5BCPE5DZC723`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/2e2de2f6-45fc-50ca-983f-2af9bb7011e8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2e2de2f6-45fc-50ca-983f-2af9bb7011e8  

## Registry profile

- **Status:** ISSUED  
- **Legal form:** `XTIQ`  
- **Source:** GLEIF  

## Provenance

- GLEIF — https://search.gleif.org/#/record/5493002T5BCPE5DZC723

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **INTELLIA THERAPEUTICS, INC.**. Human view: https://whiteintel.dev/entity/2e2de2f6-45fc-50ca-983f-2af9bb7011e8 · Structured JSON: https://whiteintel.dev/api/public/dossier/2e2de2f6-45fc-50ca-983f-2af9bb7011e8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._